Insurance companies generally consider these treatments as cosmetic rather than medical necessities
In this post Ill explain typical price ranges, what affects the cost, the evidence on results, safety points, and a simple decision guide to help you decide if its worth your money
Retatrutide is an investigational triple receptor agonist that targets the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors simultaneously
Follow the link below to Medical News Today to read the full story: Information source:
Research-community sources cluster between 20 and 100 mcg per day, given as one daily SubQ or IM injection
Description DSIP is a synthetic peptide built from nine amino acids